Track the Ind-Swift Laboratories Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Ind-Swift Laboratories Limited has published 16 insider filings. Market capitalisation: €19.5bn. The latest transaction was reported on 10 September 2024 (Sale). Among the most active insiders: ANURAG CHATURVEDI. All data is accessible without an account.
16
Insider Decl.
n/a
Thresholds
€36,415
1 ops.
Buy Volume
€237,905
15 ops.
Sell Volume
10Σ signal
Buys €36,415€237,905 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,521 of 28,717 companies
45.3
score / 100
Value
27
Quality
64
FCF yld-8.1%
Earn yld2.1%
EV/EBITDA24.3x
ROE3.2%
Gross mgn56%
Net mgn6.5%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.